Seeking Alpha

It's likely to be a rough day for Idenix Pharmaceuticals (IDIX) after yesterday's announcement...

It's likely to be a rough day for Idenix Pharmaceuticals (IDIX) after yesterday's announcement regarding IDX20963. The shares are off 33% premarket and the downgrades are coming in fast. JPMorgan, JMP, and Deutsche Bank have all cut the shares and Baird has started the stock at Underperform.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)